Jump to main content
Jump to site search

Issue 9, 2012
Previous Article Next Article

Self-complexation and complexation-controlled target cancer therapy

Author affiliations

Abstract

Target cancer therapy could be achieved by self-complexation and complexation between β-carboline–β-cyclodextrin and doxorubicin. Self-complex/complex was formed at neutral normal tissues. It converted to complex at acidic tumor tissue. Thus, doxorubicin could be targeted and carried to tumor cells. The survival of mice had been improved.

Graphical abstract: Self-complexation and complexation-controlled target cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 11 Jan 2012, accepted on 01 Apr 2012 and first published on 16 May 2012


Article type: Concise Article
DOI: 10.1039/C2MD20003A
Med. Chem. Commun., 2012,3, 1059-1061

  •   Request permissions

    Self-complexation and complexation-controlled target cancer therapy

    L. Li, M. Zhao, W. Li, Y. Wang, Z. Zhang, R. An and S. Peng, Med. Chem. Commun., 2012, 3, 1059
    DOI: 10.1039/C2MD20003A

Search articles by author

Spotlight

Advertisements